addition, tubular cell proliferation is required to recover from tubular cell death in acute kidney injury (AKI). Tumour necrosis factor (TNF) superfamily cytokines participate both in parenchymal cell injury as well as in proliferation following loss of tissue mass. In the liver, TNF-␣ promotes hepatocyte apoptosis, but type 1 TNF receptor is also required for compensatory proliferation following partial hepatectomy
. TNF-like weak inducer of apoptosis (TWEAK, TNFSF12) is a recently characterized member of the TNF superfamily of structurally related cytokines [6] . TWEAK regulates cell death, proliferation and inflammation in a cell-and microenvironment-dependent fashion [7] [8] [9] [10] [11] [12] . Fibroblast growth factor-inducible 14 (Fn14) is the TWEAK receptor [13] . Fn14 and TWEAK are present in healthy adult kidney, and their expression is up-regulated in AKI, where TWEAK contributes to amplification of inflammation [6, [14] [15] [16] . TWEAK [18] . Proliferative stimuli activate signal transduction pathways such as kinases and transcription factors that promote the progression through the cell cycle. This is controlled by the sequential formation, activation and subsequent inactivation of a series of specific cyclin-cyclin dependent kinase complexes. Cyclin levels fluctuate during the cell cycle. Cyclin D1 is a G1 cyclin and its up-regulation is required early in cell cycle progression [19] .
induces apoptosis in tubular cells cultured in an inflammatory milieu that includes interferon-␥ (IFN-␥) and TNF-␣, similar to that found
We [20] . MCT cells were cultured in RPMI 1640 (GIBCO, Grand Island, NY, USA), 10% decomplemented foetal bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin and 100 g/ml streptomycin, in 5% CO2 at 37ЊC [20] .
now report that TWEAK promotes NF-B, mitogen-activated protein kinase (MAPK) and Akt activation in renal tubular cells, leading to tubular proliferation, when the microenvironment is not inflammatory. TWEAK-induced tubular cell proliferation was observed in healthy kidneys in vivo. By contrast, TWEAK KO mice displayed an impaired hyperplastic response to unilateral nephrectomy, suggesting that this pathway plays a role in compensatory renal cell proliferation in this model. We have previously shown that in an inflammatory environment characterized by the presence of IFN-␥ and TNF-␣, TWEAK has apoptotic effects [17] and it does not promote cultured tubular cell proliferation. In an AKI model characterized by increased local IFN-␥ and TNF-␣, absence of TWEAK limited both tubular apoptosis and proliferation and the overall effect was beneficial.

Methods
Cells and reagents
MCT cells are a cultured line of proximal tubular epithelial cells harvested originally from the renal cortex of SJL mice and have been extensively characterized
Human proximal tubular epithelial (HK-2) cells (ATCC, Rockville, MD, USA) were grown on the same media as the MCT cells plus 5 g/ml insulin, 5 g/ml transferrin, 5 ng/ml sodium selenite, and 5 ng/ml hydrocortisone [15] . Results for these cells are only shown in Fig. 1E [21] . Parthenolide (Sigma) was used at 10 M. 
Cell proliferation
Experimental model of compensatory renal growth following uninephrectomy
Compensatory renal growth takes place following uninephrectomy for malignant or benign lesions or in living kidney donors. Both hypertrophy and hyperplasia contribute to kidney growth [2] . Female, 12-to 14-weekold TWEAK KO mice and WT littermate mice were used (n ϭ 7/group) [22] . Nephrectomy of the left kidney was performed following ligation of the renal vessels and ureter. The remaining kidneys were removed 48 hrs following nephrectomy, the time of peak tubular cell mitosis [2] Fig. 1A and B [7, 23] and TWEAK may translocate to the nucleus [24] . Anti-Fn14 neutralizing antibody, ITEM-4, inhibited TWEAK-induced cell proliferation (Fig. 1D) , suggesting that TWEAK induces proliferation in tubular epithelium through Fn14 activation. TWEAK blockade with anti-TWEAK antibody also prevented TWEAK-induced proliferation, confirming the specificity of the observation (Fig. 1D) . TWEAK also induced proliferation in human proximal tubular HK2 cells (Fig. 1E) . Cyclin D1 expression regulates the transit through the G1 phase of the cell cycle and is a key step in cell proliferation. TWEAK increases cyclin D1 protein expression in a time-and dose-dependent manner ( Fig. 2A and B) . 
Results
TWEAK induces tubular cell proliferation
TWEAK increased the number of cultured tubular cells in a timeand dose-dependent manner (
Modulation of the proliferative effect of TWEAK by the microenvironment
Renal tubular cells constitutively express TWEAK and Fn14 [17] . The presence of serum increased TWEAK expression at the protein, as measured by Western blot analysis and mRNA levels (Fig. 3A-C ) Constitutive Fn14 expression was increased by serum at the protein and mRNA levels (Fig. 3A-C) . In this regard, the presence of serum increased the proliferative effect of TWEAK (Fig. 3D) .
The inflammatory cytokines TNF-␣ and IFN-␥ also increase Fn14 expression in tubular cells [15] . Interestingly, the proliferative effect of TWEAK was lost in the presence of IFN-␥ and TNF-␣ (Fig. 3E) (Fig. 4A ), p38 kinase (Fig. 4B) and Akt (Fig. 4C ). "to" TWEAK promoted phosphorylation of ERK1/2 (Fig. 4A ), p38 kinase (Fig. 4B) and Akt (Fig. 4C) .
To explore the role of MAP kinases and PI3kinase/Akt signalling in TWEAK-induced proliferation, we used the specific kinase inhibitors Wortmannin (PI3kinase), PD-98059 (ERK1/2) and SB-203580 (p38) . In the presence of these inhibitors TWEAK failed to increase the number of cultured tubular cells (Fig. 5A) as well as BrdU incorporation into DNA (Fig. 5B) (Fig. 5C ). [25] . (Fig. 6B) . By contrast, parthenolide decreased TWEAKinduced proliferation (Fig. 6C) .
NF-B controls TWEAK-induced proliferation in a different pathway than MAP-kinases and PI3 kinase/Akt
NF-B plays a role in cell proliferation
In tubular cells TWEAK induces NF-B activation and this is prevented by parthenolide [15]. Inhibition of NF-B activation by parthenolide prevented TWEAK-induced increase in cell number (Fig. 6A). At this concentration parthenolide does not induce apoptosis in cultured tubular cells as assessed by flow cytometry analysis of DNA content
Because NF-B can be activated by MAP kinases and Akt [26, 27] (Fig. 6D) .
, the role of kinases in TWEAK-induced NF-B activation was studied by a reporter NF-B luciferase gene assay. Inhibition of ERK and p38 MAP kinase or phosphatidyl-inositol 3-kinase (PI3K)/AKT did not decrease NF-B activation
Fig. 2 TWEAK induces expression of cyclin D1 in a dose-and timedependent manner. Representative Western blots and quantification showing the effect of TWEAK on cyclin D1 levels in tubular cell lysates. (A) Time-course. tubular cells were stimulated with 100 ng/ml TWEAK, or (B) dose-response at 6 hrs. Mean (ϮS.E.M.) of four experiments. *P Ͻ 0.04 versus control; **P Ͻ 0.02 versus control.
In vivo actions of TWEAK on tubular cell proliferation
Tubular epithelium is the main site of Fn14 expression in the normal kidney [17] . TWEAK administration to healthy adult wild-type mice resulted in an increased number of tubular cell nuclei positive for PCNA and increased total kidney PCNA levels ( Fig. 7A and B) . This was associated with up-regulation of cyclin D1 in tubular epithelium (Fig. 7C) .
Because our data indicated that TWEAK has proliferative activities on renal tubular epithelium, we explored whether the TWEAK pathway may be involved in renal cell proliferation following unilateral nephrectomy. The expression of Fn14 was increased in remnant kidneys, both at mRNA (Fig. 8A ) and protein levels ( Fig. 8B  and C) , while TWEAK expression did not change (Fig. 8A-C) . [28] (Fig. 8D) Fig. 9A and B) . (Fig. S1) .
Immuohistochemistry localized the increased Fn14 expression to tubular cells in remnant kidneys following uninephrectomy (Fig. 8E). Renal expression of the inflammatory cytokines TNF-␣ and IFN-␥ was not increased in this model, in accordance with previous reports
. Compensatory kidney growth takes place following uninephrectomy both through hyperplasia and hypertrophy. Cell proliferation peaks at 48 hrs [2]. There was a trend towards a lower increase in kidney weight in TWEAK KO mice versus wild-type (17 Ϯ 4 versus 31 Ϯ 7 mg, P ϭ 0.08). TWEAK KO mice displayed lower tubular cell proliferation in the remnant kidney than wild-type mice (
Administration of exogenous TWEAK to uninephrectomized wild-type mice led to a further increase in renal cell proliferation, thus supporting the involvement of TWEAK in renal tubular proliferation
We next assessed the role of TWEAK on AKI. During AKI an initial wave of cell death is followed by tubular cell proliferation that leads to recovery (Fig. 10A) induced by a folic acid overdose [15] . TWEAK KO mice had both a decreased early apoptosis peak (Fig. 10B-D) , as well as a decreased late cell proliferation peak (Fig. 11A and B) . Overall, renal function was better in TWEAK KO mice and there was no impact over functional recovery (Fig. 11C) . These data are consistent with the pro-apoptotic action of TWEAK in an inflammatory milieu in cultured tubular cells [15] . Prophylactic treatment with anti-TWEAK antibodies [15] [15, 17] [29] [30] [31] . TWEAK actions on renal cells are modulated by the cell microenvironment [17] . The proliferative effect is enhanced in the presence of the mitotic factors from FBS. Serum increased both TWEAK and Fn14 expression and this may facilitate an increased proliferative response. Inflammatory Fig. 4 TWEAK activates cytokines also increase Fn14 expression [17] However, in their presence TWEAK potentiates cell death [17] . Because our studies identify the Fn14 receptor as the mediator of both the proliferative and the lethal potential of TWEAK [17] [11, 12, [33] [34] [35] . [35] . In addition TWEAK activated PI3K/Akt in osteoblastic cells [36] but inhibited insulin-induced Akt activation in hepatocytes [37] .
Discussion
TWEAK is a member of the TNF superfamily of cytokines that regulates apoptosis and inflammation in tubular cells
However, there is little information on the molecular pathways leading to TWEAK-mediated proliferation. As is the case for tubular cells, in endothelial cells TWEAK potentiates the mitogenic activity of other mitogens that increase Fn14 receptor expression, such as FGF-2 and VEGF-A. In endothelial cells TWEAK activated NF-B, ERK1/2 and JNK1/2, but not p38 MAPK
The role of these pathways in TWEAK-induced cell proliferation was not explored. TWEAK induction of NF-B activation in tubular cells has been extensively characterized in relation to its pro-inflammatory role [15]. In addition, in tubular cells ERK, p38 MAPK, PI3K/Akt and NF-B cooperate in TWEAK-induced proliferation in a manner that disruption of one of them prevents proliferation.
The proliferative action of TWEAK was also observed in vivo in healthy kidneys from wild-type mice injected with exogenous TWEAK. In addition, TWEAK contributed to renal cell proliferation in compensatory renal growth following nephrectomy. This is a situation characterized by tubular cell proliferation in the absence of tubular injury or increased expression of inflammatory cytokines [2] . No increased expressions of TNF-␣ or IFN-␥, factors that in association with TWEAK promote tubular cell death [17] were noted in this model. This is in accordance with previous reports [28] [17] . Consistent with the cell culture data, in an AKI model characterized by renal inflammation and increased local levels of TWEAK, Fn14, TNF-␣ and IFN-␥ [15, 17] , the lack of TWEAK decreased tubular cell apoptosis. In this model, as in other models of AKI, an initial wave of cell death is followed by tubular cell proliferation (Fig. 10A) 
